Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Beam Therapeutics

5 Disclosed Funding Rounds $689,000,000

0 Participating Investments


Therapeutics, Genetics, Biotechnology, Medical

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Cambridge, Massachusetts, United States, North America (US)

Organizations in Cambridge in Therapeutics,
Organizations in Cambridge in Genetics,
Organizations in Cambridge in Biotechnology,
Organizations in Cambridge in Medical,
Organizations in Massachusetts in Therapeutics,
Organizations in Massachusetts in Genetics,
Organizations in Massachusetts in Biotechnology,
Organizations in Massachusetts in Medical,
Organizations in United States in Therapeutics,
Organizations in United States in Genetics,
Organizations in United States in Biotechnology,
Organizations in United States in Medical,
Organizations in North America in Therapeutics,
Organizations in North America in Genetics,
Organizations in North America in Biotechnology,
Organizations in North America in Medical

Investors in Cambridge in Therapeutics,
Investors in Cambridge in Genetics,
Investors in Cambridge in Biotechnology,
Investors in Cambridge in Medical,
Investors in Massachusetts in Therapeutics,
Investors in Massachusetts in Genetics,
Investors in Massachusetts in Biotechnology,
Investors in Massachusetts in Medical,
Investors in United States in Therapeutics,
Investors in United States in Genetics,
Investors in United States in Biotechnology,
Investors in United States in Medical,
Investors in North America in Therapeutics,
Investors in North America in Genetics,
Investors in North America in Biotechnology,
Investors in North America in Medical

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 2017

Founders J. Keith Joung, David R. Liu, Feng Zhang

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Company Type For Profit


Twitter Link

LinkedIN Link

Wikipedia Link

Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. Beam is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Date Round Raised Lead
January, 19, 2021 Post-IPO Equity $260,000,000 -------
February, 11, 2020 Post-IPO Equity $207,000,000 -------
March, 06, 2019 Series B $135,000,000 -------
May, 14, 2018 Series A $87,000,000 ARCH Venture Partners, F-Prime Capital
April, 27, 2018 Series A $13,000,000 F-Prime Capital, ARCH Venture Partners

Beam Therapeutics Investors (18)

Investor Lead? Round Participating Raise Date Partners
Perceptive Advisors No Post-IPO Equity $260,000,000 January, 19, 2021 -------
Casdin Capital No Post-IPO Equity $260,000,000 January, 19, 2021 -------
Farallon Capital Management No Post-IPO Equity $260,000,000 January, 19, 2021 -------
Redmile Group No Post-IPO Equity $260,000,000 January, 19, 2021 -------
Cormorant Asset Management No Post-IPO Equity $260,000,000 January, 19, 2021 -------
Redmile Group No Series B $135,000,000 March, 06, 2019 -------
Cormorant Asset Management No Series B $135,000,000 March, 06, 2019 -------
Omega Funds No Series B $135,000,000 March, 06, 2019 -------
Altitude Life Science Ventures No Series B $135,000,000 March, 06, 2019 -------
F-Prime Capital No Series B $135,000,000 March, 06, 2019 -------
ARCH Venture Partners No Series B $135,000,000 March, 06, 2019 -------
GV No Series B $135,000,000 March, 06, 2019 -------
Eight Roads Ventures No Series B $135,000,000 March, 06, 2019 -------
ARCH Venture Partners Yes Series A $87,000,000 May, 14, 2018 -------
F-Prime Capital Yes Series A $87,000,000 May, 14, 2018 -------
OUP (Osage University Partners) No Series A $87,000,000 May, 14, 2018 -------
F-Prime Capital Yes Series A $13,000,000 April, 27, 2018 -------
ARCH Venture Partners Yes Series A $13,000,000 April, 27, 2018 -------